Screening of Hemolytical Streptococcus of Group B in Pregnancy and Prevention of Infection in Newborns;Skríning Hemolytického Streptokoka Skupiny B v Tehotnosti a Prevencia Infekcie Novorodencov

Ceska Gynekologie

Volumn 69, Issue 2, 2004, Pages 91-94

  Janek, L'udovít ^a,b   Holoman K ^a   Suska P ^a   Gavornik E ^a   Horakova E ^a   Krizko M Ml ^a  

^a LFUK   (Slovakia)

^b LFUK   (Slovakia)

Author keywords

GBS disease; Group B streptococcus; Streptococcus agalactiae

Indexed keywords

CLINDAMYCIN; PENICILLIN G;

ANTIBIOTIC THERAPY; ANUS; ARTICLE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BETA HEMOLYTIC STREPTOCOCCUS; BIRTH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG HYPERSENSITIVITY; HUMAN; INCIDENCE; INFECTION PREVENTION; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN DISEASE; NEWBORN INFECTION; NEWBORN SCREENING; NONHUMAN; PERINATAL DEATH; PREGNANCY; PROSPECTIVE STUDY; SLOVAKIA; VAGINA;

ANAL CANAL; ANTI-BACTERIAL AGENTS; CARRIER STATE; FEMALE; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; VAGINA;

EID: 1942443835     PISSN: 12107832     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. AAP, Committee on Infectious Diseases/Committee on Fetus and Newborn: Revised guidelines for prevention of early-onset group B streptococcal (GBS) disease. Pediatrics, 99, 1997, s. 489-496.
2. ACOG, Committee on Obstetrics Practice: Prevention of early-onset streptococcal disease in newborns (opinion 173). Washington D. C.: American College of Obstetricians and Gynaecologists, 1996.
3. Boyer, K. M., Gotoff, S. P.: Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. r. Eng. J. Med., 314, 1986, s. 1665-1669.
4. CDC: Prevention of perinatal group B streptococcal disease: a public health perspective. Morbidity and Mortality Weekly Report, 45, 1996, s. 1-24.
5. CDC: Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC, 2002. http: //www.cdc.gov/mmwr/preview/mmwrhtml/rr5111a1.htm
6. Dars, M. A., Gray, B. M., Khare, S.: Prospective studies of group B streptococcal infections in infant. J. Pediatr., 95, 1979, s. 437-443.
7. Faro, S.: Group B beta-haemolytic streptococci and puerperal infections. Am. J. Obstet. Gynecol., 139, 1981, s. 137-152.
8. Frabciosi, R. A., Knostman, J. D., Zimmerman, R. A.: Group B streptococcal neonatal and infant infections. J. Pediatr., 82, 1973, s. 719-723.
9. Janek L., Holomáň, K., Šuška, P., et al.: Skrining Streptococcus agalactiae v tehotnosti a intrapartálna ATB profylaxia. Slov. Gynecol. Pôrod., 9, 2002, s. 170-174.
10. Kenyon, S. L., Taylor, D. J., Tarnow-Mordi, W.: Broad spectrum antibiotics for spontaneous preterm labour: the ORACLE II randomised trial. Lancet, 357, 2001, s. 989-994.
11. Opal, S. M., Cors, A., Palmer, M.: Group B streptococcal infection in adults and infants. Arch. Intern. Med., 148, 1988, s. 641-645.
12. Schrag, S. J., Zell, E. R., Lynfeld, R., et al.: A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. Engl. J. Med., 347, 2002, s. 233-239.
13. Schrag, S. J., Zywicki, S., Farlez, M. M., et al.: Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. A Engl. J. Med., 342, 2000, s. 15-20.
14. Schuchat, A., Oxtoby, M., Cochi, S.: Population based risk factors for neonatal group B streptococcal disease: result of a cohort study in metropolitan Atlanta. J. Infect. Dis., 102, 1990, s. 672-677.
15. Smaill, F.: Intrapartum antibiotics for group B streptococcal colonisation (Cochrane Review). In: The Cochrane Library, 1, 2002, Oxford: Update Software.
16. Spelerberg, B.: Pathogenesis of neonatal Streptococcus agalactiae infections. Microbes and infections, 2, 2000, s. 1733-1742.
17. Stoll, B. J., Hansen, N., Faranoff, A. A., et al.: Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N. Engl. J. Med., 347, 2002, s. 240-247.
18. Zangwill, K. M., Schuschat, A., Wenger, J. D.: Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system. MMWR, 41, 1992, s. 25-32.